femoropopliteal lesions

临床试验

计划入组 50 人 · 首次发布于 2016 年 4 月 12 日

招募中

NCT06713850

Angioplasty With Shockwave IVL Catheter System in Femoropopliteal Lesions

计划入组 130 人 · 首次发布于 2024 年 12 月 3 日

已完成

NCT06173960

3-year Follow-up of Patients Treated With Jetstream Combined With Ranger for Calcified Femoropopliteal Lesions

计划入组 50 人 · 首次发布于 2023 年 12 月 18 日

药物

查看全部 21 →

Small Molecule

Investigational

LTX-315

C₇₈H₁₀₆N₁₈O₉

Small Molecule

Approved

Urea(Cem-urea, Umecta, Utopic)

相关疾病：Allergic Skin Reaction, Atopic Dermatitis，另有 17 项

CH₄N₂O

Small Molecule

Approved

Nitrogen(Nitrogen NF)

相关疾病：Actinic Keratosis (AK), Benign skin lesions，另有 2 项

N₂

机构

查看全部 15 →

Regions Hospital

United States

Lessors, Incorporated

United States

Regions Financial

资讯

查看全部 1063 →

去年

VIVA24: Late-Breaking Trials Highlight Advances in Peripheral Artery Disease Treatment

去年

Endovascular Advancements: New Devices and Strategies Emerge for PAD and CLTI

去年

临床试验

Determining Predictors of Restenosis in Femoropopliteal Lesions

Angioplasty With Shockwave IVL Catheter System in Femoropopliteal Lesions

3-year Follow-up of Patients Treated With Jetstream Combined With Ranger for Calcified Femoropopliteal Lesions

药物

LTX-315

Urea(Cem-urea, Umecta, Utopic)

Nitrogen(Nitrogen NF)

机构

Regions Hospital

Lessors, Incorporated

Regions Financial

资讯

VIVA24: Late-Breaking Trials Highlight Advances in Peripheral Artery Disease Treatment

Endovascular Advancements: New Devices and Strategies Emerge for PAD and CLTI

Philips Initiates U.S. Clinical Trial for Integrated Laser Atherectomy and Lithotripsy Device in PAD